Certificate PL-26-00262 · PEG-MGF 2 mg · lot PL-2610-148
VerifyCertificate page
PrymaLab
PrymaLab
PrymaLab Analytical · In-house laboratory
3705 Music Branch Rd, Ashland, KY 41102 · +1 (606) 465-9063 · prymalab.net
Certificate no.
PL-26-00262
Verification key
GRYQQTH9
Scan or enter both at
prymalab.net/testing/verify

Certificate of Analysis · Lot release

PEG-MGF 2 mg

Lot PL-2610-148 · Lyophilized powder · Label claim 2 mg per vial
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2610-148
Date made
2026-10-06
Date of analysis
2026-10-07
Date issued
2026-10-21
Retest / expiry
2028-10-06
Units in lot / sampled
299 / 2
Storage
−20 °C, desiccated, dark
Certificate type
Lot COA, 2 pages
Compound
PEG-MGF
PEGylated mechano growth factor: the IGF-1Ec E-domain 24-mer carrying a polydisperse PEG
CAS number
n/a
Molecular formula
C121H200N42O39 (core 24-mer before PEGylation)
Theoretical mass (avg.)
2,867.20 Da
Sequence
24-aa MGF core + PEG
Purity · RP-HPLC, area %
99.29%
Specification ≥ 99.0% • main peak at 14.34 min
Identity · Observed Mass
2,867.24 Da
Theoretical 2,867.20 Da • +0.04 Da (14 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da2,867.24 DaPASS
PurityRP-HPLC, UV 214 nm, area%≥ 99.0%99.29%PASS
Largest impurityRP-HPLC, area%≤ 1.0%0.43% (RT 15.50)PASS
Water contentKarl Fischer≤ 5.0%1.87%PASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.069 EU/mgPASS
SterilityUSP <71>, 14-dayNo growthNo growthPASS

1HPLC chromatogram

Data file: PL-2610-148-HPLC.raw · Column C18, 150 × 4.6 mm · UV 214 nm
0.01%0.1%1%10%100%121314151617Retention time (min) · stick height = area % (log scale)99.29% · 14.34 min0.11% †0.17% †0.43% †
Peak plot drawn from the integrated peak table (area %, log scale); it is not the instrument trace, which is retained in PL-2610-148-HPLC.raw. † Nominal reference retention time for the assigned impurity; the main-peak RT is observed in this lot.
PrymaLab
PrymaLab
Certificate of Analysis · continued
PEG-MGF 2 mg · Lot PL-2610-148 · Certificate PL-26-00262
Lot PL-2610-148
Method, peak table and approval

2HPLC method · PL-2610-148-HPLC.raw

Instrument
Waters Alliance e2695
Data System
Empower 3
Detector
UV absorbance
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Gradient
5–95% B over 25 min (linear)
Flow Rate
1.0 mL/min
Column Temperature
40 °C
Injection Volume
10 µL

3Gradient program

Time (min)% A% B
0.0955
25.0595

4Peak table

PeakRT (min)AreaArea %
113.00 †—0.11
213.80 †—0.17
314.34—99.29
415.50 †—0.43
Total—100.00
Peaks: 1 deamidation product; 2 truncated sequence; 3 main peak (PEG-MGF); 4 unpegylated form · Area % from the integrated peak table (absolute areas are not part of the lot-release export) · † nominal reference RT for the assigned impurity · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters SQD
Ionization / Mode
ESI, positive
Reference m/z (charge)
956.74 (3+) · 717.81 (4+)
Deconvoluted Mass
2,867.24 Da
Theoretical Mass
2,867.20 Da
Difference
+0.04 Da (14 ppm)
Data File
PL-2610-148-MS.d
Acceptance
Within ± 1.0 Da

6Additional tests

TestPerformed byDateReport / file
Water content (Karl Fischer)PrymaLab Analytical2026-10-07—
Endotoxin (LAL, kinetic)PrymaLab Analytical2026-10-07—
Sterility (USP <71>, day-14 read-out)PrymaLab Analytical2026-10-21—
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-10-21
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-21
M. Phelps
Lab Director · approved for release
Date: 2026-10-21